Details for New Drug Application (NDA): 203978
✉ Email this page to a colleague
NDA 203978 describes NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE, which is a drug marketed by Inforlife and is included in one NDA. Additional details are available on the NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE profile page.
The generic ingredient in NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
The generic ingredient in NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
Summary for 203978
| Tradename: | NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE |
| Applicant: | Inforlife |
| Ingredient: | nicardipine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 203978
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 20MG/200ML (0.1MG/ML) | ||||
| Approval Date: | Apr 17, 2024 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 40MG/200ML (0.2MG/ML) | ||||
| Approval Date: | Apr 17, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
